Tag Archives: Stock

Artificial intelligence (AI) software company Palantir (NASDAQ: PLTR) has a strong case as the most talked-about stock this year. The success of its AI tools amid the current AI boom has made it one of the more high-profile stocks on the market, and its stock price has followed the hype. Its stock is up 143% year to date through Aug. …

Switch the Market flag for targeted data from your country of choice. Open the menu and switch the Market flag for targeted data from your country of choice. Need More Chart Options? Right-click on the chart to open the Interactive Chart menu. Use your up/down arrows to move through the symbols. Source link

Meta Platforms sees largest increase in short interest of any U.S. stock this year, S3 says Meta Platforms, which dropped 2.3% on Monday, has seen the largest increase in short interest of any U.S. stock this year, according to S3 Partners, which specializes in tracking the activity of short sellers, who try and profit from a decline in a company’s …

Intel Stock Drops on Report of 10% Equity Stake Via the Chips Act  Barron’s Trump Administration in Talks to Take a 10% Stake in Intel  Bloomberg.com Wells Fargo hikes S&P 500 target as U.S. tariffs get delayed again  CNBC Intel’s Move Toward Nationalization Won’t Work—at Least for the Long Haul  The Wall Street Journal What might Trumpian meddling mean for Intel?  The Economist Source link

Stock Market Today: Dow slips, S&P 500 and Nasdaq struggle for direction with Ukraine talks in focus; Wall Street awaits Powell’s Friday speech at Jackson Hole  MarketWatch Stocks dip to start the week as traders await Powell speech, retail earnings: Live updates  CNBC Wall Street slips ahead of Jackson Hole summit, retailers’ earnings  Reuters Stock market today: Dow, S&P 500, Nasdaq stall with …

Wegovy News Pushes Novo Nordisk Stock Higher  Barron’s Novo Nordisk shares pop after Wegovy receives U.S. approval for liver disease  CNBC Wegovy Gets F.D.A. Approval for MASH  The New York Times Novo’s Wegovy becomes first GLP-1 drug approved for MASH  BioPharma Dive FDA Approves Novo Nordisk’s Wegovy for Liver Disease  The Wall Street Journal Source link

Nvidia Stock Rises. Why Next-Gen Chip Concerns Are Overblown.  Barron’s Nvidia’s AI Expansion Could Push Revenue To $300 Billion By 2026, Analyst Says  Yahoo Finance Morgan Stanley maintains bullish stance on Nvidia heading into earnings, raises price target  CNBC Nvidia’s Q2 Preview: The GB300 Surprise Few See Coming (NASDAQ:NVDA)  Seeking Alpha Here’s Why Nvidia Outperforms Out to 2028  The Motley Fool Source link

Stock Market Today: Dow Futures Edge Lower Ahead of Trump-Zelensky Meeting — Live Updates  The Wall Street Journal European stocks, US dollar drift as traders eye Ukraine talks  Reuters Emerging-Market Assets Inch Higher Before Ukraine, Fed Meetings  Bloomberg.com Asia-Pacific markets close mostly higher as investors await U.S.-Ukraine talks  CNBC Trump Ukraine Meeting Today Can Upend Oil Prices. It isn’t the Only Crunch Point for …

U.S. stock futures inch higher following Trump-Putin summit; Wall Street awaits Fed’s Jackson Hole meeting  MarketWatch Global stocks near record highs as markets await Trump-Putin talks  Reuters Stocks Slide After Data as Trump-Putin in Focus: Markets Wrap  Bloomberg.com Which Stocks, Commodities Might Trump-Putin Summit Impact?  Investor’s Business Daily What Business Will Be Watching For in the Trump-Putin Talks  The New York Times Source link

Take an industry leader, add in a healthy dose of secular tailwinds and a large addressable market, and you get an artificial intelligence (AI) pioneer ready to break new ground. Artificial intelligence (AI) has stolen the limelight over the past few years, and there’s plenty of evidence to suggest this is just the beginning. Developers continue to create new applications …